Sacituzumab a ' Step Forward ' in Breast Cancer Unmet Need Sacituzumab a ' Step Forward ' in Breast Cancer Unmet Need

Sacituzumab govitecan (Trodelvy) beat chemotherapy in patients with heavily pretreated endocrine resistant HR+/HER2- advanced breast cancer, who represent a ' great clinical unmet need, ' says expert.Medscape Medical News

Source: Medscape Medical News Headlines - June 6, 2022 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news